Literature DB >> 16611689

C. elegans dystroglycan DGN-1 functions in epithelia and neurons, but not muscle, and independently of dystrophin.

Robert P Johnson1, Seong Hoon Kang, James M Kramer.   

Abstract

The C. elegans dystroglycan (DG) homolog DGN-1 is expressed in epithelia and neurons, and localizes to basement membrane (BM) surfaces. Unlike vertebrate DG, DGN-1 is not expressed in muscle or required for muscle function. dgn-1 null mutants are viable but sterile owing to severe disorganization of the somatic gonad epithelium, and show defects in vulval and excretory cell epithelia and in motoneuron axon guidance. The defects resemble those of epi-1 laminin alphaB mutants, suggesting that DGN-1 serves as a receptor for laminin. dgn-1(0)/+ animals are fertile but show gonad migration defects in addition to the defects seen in homozygotes, indicating that DGN-1 function is dosage sensitive. Phenotypic analyses show that DGN-1 and dystrophin-associated protein complex (DAPC) components have distinct and independent functions, in contrast to the situation in vertebrate muscle. The DAPC-independent functions of DGN-1 in epithelia and neurons suggest that vertebrate DG may also act independently of dystrophin/utrophin in non-muscle tissues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611689     DOI: 10.1242/dev.02363

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  36 in total

1.  C. elegans dystroglycan coordinates responsiveness of follower axons to dorsal/ventral and anterior/posterior guidance cues.

Authors:  Robert P Johnson; James M Kramer
Journal:  Dev Neurobiol       Date:  2012-07-27       Impact factor: 3.964

2.  Niche Cell Wrapping Ensures Primordial Germ Cell Quiescence and Protection from Intercellular Cannibalism.

Authors:  Daniel C McIntyre; Jeremy Nance
Journal:  Curr Biol       Date:  2020-01-30       Impact factor: 10.834

3.  Dystroglycan does not contribute significantly to kidney development or function, in health or after injury.

Authors:  George Jarad; Jeffrey W Pippin; Stuart J Shankland; Jordan A Kreidberg; Jeffrey H Miner
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-05

4.  A new role for laminins as modulators of protein toxicity in Caenorhabditis elegans.

Authors:  Louise T Jensen; Tine H Møller; Simon A Larsen; Helle Jakobsen; Anders Olsen
Journal:  Aging Cell       Date:  2011-12-11       Impact factor: 9.304

Review 5.  The Caenorhabditis elegans epidermis as a model skin. II: differentiation and physiological roles.

Authors:  Andrew D Chisholm; Suhong Xu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-06-19       Impact factor: 5.814

6.  Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.

Authors:  Alison K Esser; Michael B Cohen; Michael D Henry
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

Review 7.  Basement Membranes in the Worm: A Dynamic Scaffolding that Instructs Cellular Behaviors and Shapes Tissues.

Authors:  Matthew R Clay; David R Sherwood
Journal:  Curr Top Membr       Date:  2015-09-12       Impact factor: 3.049

8.  Searching for signaling balance through the identification of genetic interactors of the Rab guanine-nucleotide dissociation inhibitor gdi-1.

Authors:  Anna Y Lee; Richard Perreault; Sharon Harel; Elodie L Boulier; Matthew Suderman; Michael Hallett; Sarah Jenna
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

9.  Global prediction of tissue-specific gene expression and context-dependent gene networks in Caenorhabditis elegans.

Authors:  Maria D Chikina; Curtis Huttenhower; Coleen T Murphy; Olga G Troyanskaya
Journal:  PLoS Comput Biol       Date:  2009-06-19       Impact factor: 4.475

10.  Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress.

Authors:  Vincent Mirouse; Christina P Christoforou; Cornelia Fritsch; Daniel St Johnston; Robert P Ray
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.